M4773

Metaraminol (+)-bitartrate salt

α-adrenoceptor agonist

• Sinónimos: (−)-m-Hydroxyphenylpropanolamine bitartrate salt
• Fórmula empírica (notación de Hill): C₉H₁₃NO₂ · C₄H₆O₆
• Número CAS: 33402-03-8
• Peso molecular: 317.29
• NACRES: NA.77
• PubChem Substance ID: 24896944
• UNSPSC Code: 12352200
• EC Number: 251-502-3
• MDL number: MFCD00238763

Propiedades

• Nombre del producto: Metaraminol (+)-bitartrate salt,
• Quality Segment: 200
• originator: Merck & Co., Inc., Kenilworth, NJ, U.S.
• SMILES string: O[C@H]([C@@H](O)C(O)=O)C(O)=O.C[C@H](N)[C@H](O)c1cccc(O)c1
• InChI: 1S/C9H13NO2.C4H6O6/c1-6(10)9(12)7-3-2-4-8(11)5-7;5-1(3(7)8)2(6)4(9)10/h2-6,9,11-12H,10H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t6-,9-;1-,2-/m01/s1
• InChI key: VENXSELNXQXCNT-IJYXXVHRSA-N

Descripción

Application

Metaraminol (+)-bitartrate salt has been used to study the effects of adrenergic agonists in the mouse model of endometriosis.

Biochem/physiol Actions

α-adrenoceptor agonist.
Metaraminol may serve as a false sympathetic transmitter. It is a mixed α - and β-adrenergic agonist.

Features and Benefits

This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Información de seguridad

• pictograms: GHS06
• signalword: Danger
• hcodes: H301 + H311 + H331
• pcodes: P261 - P264 - P280 - P301 + P310 - P302 + P352 + P312 - P304 + P340 + P311
• Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral
• Clase de almacenamiento: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk: WGK 3
• ppe: Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges